6 results
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Drugs #Antiarrhythmic ... #Pharmacology # ... Cardiology #Table ... #Effects
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Clinically Significant ... Cardiovascular Drug-Drug ... arrhythmias Class I Antiarrhythmic ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... #medications #table ... #decisionaid #cardiology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... significant adverse effects ... • TB expert medical ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... won’t have any clinical ... effect.
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
fatigue, altered mental ... #differential #algorithm ... #management #cardiology ... #treatment #table ... #pharmacology